Porta, E.O.J.; AlKharboush, D.F.; Jackson, L.; Pang, F.; Darin, A.; Louka, J.; Quamruzzaman, M.; Shi, X.; Wells, G.; Kozielski, F.
Targeting SARS-CoV-2 Non-Structural Proteins: A Blueprint for Next-Generation Small-Molecule Coronavirus Antivirals. Pharmaceutics 2026, 18, 693.
https://doi.org/10.3390/pharmaceutics18060693
AMA Style
Porta EOJ, AlKharboush DF, Jackson L, Pang F, Darin A, Louka J, Quamruzzaman M, Shi X, Wells G, Kozielski F.
Targeting SARS-CoV-2 Non-Structural Proteins: A Blueprint for Next-Generation Small-Molecule Coronavirus Antivirals. Pharmaceutics. 2026; 18(6):693.
https://doi.org/10.3390/pharmaceutics18060693
Chicago/Turabian Style
Porta, Exequiel O. J., Dana F. AlKharboush, Lauren Jackson, Felix Pang, Aylin Darin, Joy Louka, Mohammed Quamruzzaman, Xinyue Shi, Geoffrey Wells, and Frank Kozielski.
2026. "Targeting SARS-CoV-2 Non-Structural Proteins: A Blueprint for Next-Generation Small-Molecule Coronavirus Antivirals" Pharmaceutics 18, no. 6: 693.
https://doi.org/10.3390/pharmaceutics18060693
APA Style
Porta, E. O. J., AlKharboush, D. F., Jackson, L., Pang, F., Darin, A., Louka, J., Quamruzzaman, M., Shi, X., Wells, G., & Kozielski, F.
(2026). Targeting SARS-CoV-2 Non-Structural Proteins: A Blueprint for Next-Generation Small-Molecule Coronavirus Antivirals. Pharmaceutics, 18(6), 693.
https://doi.org/10.3390/pharmaceutics18060693
